IGFBP2 levels in control men were 279.4 (231.6–327.3) ng/mL versus 99.3 (79.2–119.3) ng/mL and 97.2 (81.6–11.8) ng/mL in subjects with NAFL and NASH, respectively (both p < 0.001 versus controls) (Figure 6A). Here, IGFBP2 is linked to metabolic dysfunction-associated steatohepatitis.